The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase

碩士 === 國立臺灣大學 === 醫學工程學研究所 === 106 === Osteoarthritis (OA) is a chronic joint injury disease. Its progressive course leads to cartilage fibrosis due to tissue nature to not easy to recover after damage. Present aids for OA are primarily focuses for alleviating the symptoms of the disease rather than...

Full description

Bibliographic Details
Main Authors: Felicia Boendadjaja, 溫麗潞
Other Authors: Feng-Huei Lin
Format: Others
Language:en_US
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/edaydb
id ndltd-TW-106NTU05530052
record_format oai_dc
spelling ndltd-TW-106NTU055300522019-05-30T03:50:56Z http://ndltd.ncl.edu.tw/handle/edaydb The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase 白芨多醣體與白藜蘆醇應用於預防及早期治療退化性關節炎 Felicia Boendadjaja 溫麗潞 碩士 國立臺灣大學 醫學工程學研究所 106 Osteoarthritis (OA) is a chronic joint injury disease. Its progressive course leads to cartilage fibrosis due to tissue nature to not easy to recover after damage. Present aids for OA are primarily focuses for alleviating the symptoms of the disease rather than prevent or cure the disease process. Therefore, development of new therapeutic strategies and biomaterials are always on-demand for OA regenerative medicine. It has been reported that resveratrol can inhibit the inflammatory rate of OA, but bioavailability of resveratrol is still controversy. In order to improve this point, the polysaccharide isolated from Bletilla striata (BSP) is added. Recent studies found that BSP has anti­oxidative and anti-inflammatory properties, which can strengthen the role of resveratrol to provide an anti-inflammatory effect. In this study, a mixture of 50 μM resveratrol and 100 µg/mL BSP (RB) was tested for cytotoxicity potential, then applied to an experimental model of OA-like chondrocytes induced by lipopolysaccharide (LPS) thus evaluated its ECM activity and gene expression. The experimental results showed that the BSP have the correct functional groups, and RB has been proved to have good biocompatibility through the WST-1 test and LIVE/DEAD staining. ICC type II collagen, Alcian blue staining, and gene expression evaluation showed that RB able to maintained the expression of ECM and inflammatory-related genes caused by LPS-stimulated chondrocyte, could be effectively reduced. To conclude, BSP can significantly maintain the expression of extracellular matrix, while resveratrol can reduce the symptoms of inflammation, and the mixture of BSP and resveratrol has the advantages of both, so it has great potentials for OA early treatment and prevention. Feng-Huei Lin 林峯輝 2018 學位論文 ; thesis 60 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 國立臺灣大學 === 醫學工程學研究所 === 106 === Osteoarthritis (OA) is a chronic joint injury disease. Its progressive course leads to cartilage fibrosis due to tissue nature to not easy to recover after damage. Present aids for OA are primarily focuses for alleviating the symptoms of the disease rather than prevent or cure the disease process. Therefore, development of new therapeutic strategies and biomaterials are always on-demand for OA regenerative medicine. It has been reported that resveratrol can inhibit the inflammatory rate of OA, but bioavailability of resveratrol is still controversy. In order to improve this point, the polysaccharide isolated from Bletilla striata (BSP) is added. Recent studies found that BSP has anti­oxidative and anti-inflammatory properties, which can strengthen the role of resveratrol to provide an anti-inflammatory effect. In this study, a mixture of 50 μM resveratrol and 100 µg/mL BSP (RB) was tested for cytotoxicity potential, then applied to an experimental model of OA-like chondrocytes induced by lipopolysaccharide (LPS) thus evaluated its ECM activity and gene expression. The experimental results showed that the BSP have the correct functional groups, and RB has been proved to have good biocompatibility through the WST-1 test and LIVE/DEAD staining. ICC type II collagen, Alcian blue staining, and gene expression evaluation showed that RB able to maintained the expression of ECM and inflammatory-related genes caused by LPS-stimulated chondrocyte, could be effectively reduced. To conclude, BSP can significantly maintain the expression of extracellular matrix, while resveratrol can reduce the symptoms of inflammation, and the mixture of BSP and resveratrol has the advantages of both, so it has great potentials for OA early treatment and prevention.
author2 Feng-Huei Lin
author_facet Feng-Huei Lin
Felicia Boendadjaja
溫麗潞
author Felicia Boendadjaja
溫麗潞
spellingShingle Felicia Boendadjaja
溫麗潞
The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
author_sort Felicia Boendadjaja
title The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
title_short The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
title_full The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
title_fullStr The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
title_full_unstemmed The Evaluation of Polysaccharide from Bletilla Striata Mixed with Resveratrol for Osteoarthritis Prevention in Early Phase
title_sort evaluation of polysaccharide from bletilla striata mixed with resveratrol for osteoarthritis prevention in early phase
publishDate 2018
url http://ndltd.ncl.edu.tw/handle/edaydb
work_keys_str_mv AT feliciaboendadjaja theevaluationofpolysaccharidefrombletillastriatamixedwithresveratrolforosteoarthritispreventioninearlyphase
AT wēnlìlù theevaluationofpolysaccharidefrombletillastriatamixedwithresveratrolforosteoarthritispreventioninearlyphase
AT feliciaboendadjaja báijīduōtángtǐyǔbáilílúchúnyīngyòngyúyùfángjízǎoqīzhìliáotuìhuàxìngguānjiéyán
AT wēnlìlù báijīduōtángtǐyǔbáilílúchúnyīngyòngyúyùfángjízǎoqīzhìliáotuìhuàxìngguānjiéyán
AT feliciaboendadjaja evaluationofpolysaccharidefrombletillastriatamixedwithresveratrolforosteoarthritispreventioninearlyphase
AT wēnlìlù evaluationofpolysaccharidefrombletillastriatamixedwithresveratrolforosteoarthritispreventioninearlyphase
_version_ 1719196047268380672